Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 2;12(1):15.
doi: 10.1186/s44156-025-00078-z.

British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of adult patients with obstructive hypertrophic cardiomyopathy receiving myosin-inhibitor therapy

Clare M Culshaw  1 , Daniel Augustine  2   3 , Caroline J Coats  4 , Ivo Andrade  5 , Keith Pearce  5 , Antonis Pantazis  6 , William Bradlow  7 , Lauren Turvey  7 , William Moody  8 , Lynne Williams  9 , Rachel Bastianen  10 , Jane Draper  10 , David L Oxborough  11 , Robert M Cooper  12   13
Affiliations
Review

British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of adult patients with obstructive hypertrophic cardiomyopathy receiving myosin-inhibitor therapy

Clare M Culshaw et al. Echo Res Pract. .
No abstract available

Keywords: Mavacamten; Myosin-inhibitor; Obstructive HCM; Surveillance Echocardiogram.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Recommended algorithm for patients who are normal and rapid CYP metabolisers. *Interrupt treatment at any point if LVEF <50%
Fig. 2
Fig. 2
Recommended algorithm for patients who are slow/poor CYP metabolisers or while CYP status is pending. *Interrupt treatment at any point if LVEF <50%
Fig. 3
Fig. 3
Maintenance assessment algorithm. Echocardiography should be performed every 24 weeks unless a dose titration is needed or LVEF drops to < 50%
Fig. 4
Fig. 4
Actions if LVEF drops to < 50%. If at any visit the patient’s LVEF is < 50%, the treatment should be interrupted for at least 4 weeks and only restarted if LVEF ≥ 50%
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. NICE. Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy. 2023. https://www.nice.org.uk/guidance/ta913 - PubMed
    1. Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Bezzina CR, Biagini E, Blom NA, de Boer RA, De Winter T, Elliott PM, Flather M, Garcia-Pavia P, Haugaa KH, Ingles J, Jurcut RO, Klaassen S, Limongelli G, Loeys B, Mogensen J, Olivotto I, Pantazis A, Sharma S, Peter Van Tintelen J, Ware JS, Kaski JP, ESC Scientific Document Group. 2023 ESC guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European society of cardiology (ESC). Eur Heart J. 2023;44(37):3503–626. 10.1093/eurheartj/ehad194. - PubMed
    1. Marian AJ, Braunwald E. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017;121(7):749–70. - PMC - PubMed
    1. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, Evanovich LL, Hung J, Joglar JA, Kantor P, Kimmelstiel C, Kittleson M, Link MS, Maron MS, Martinez MW, Miyake CY, Schaff HV, Semsarian C, Sorajja P. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2020;142(25):e558–631. 10.1161/CIR.0000000000000937. - PubMed
    1. Lopes LR, Aung N, van Duijvenboden S, Munroe PB, Elliott PM, Petersen SE. Prevalence of hypertrophic cardiomyopathy in the UK Biobank population. JAMA Cardiol. 2021;6(7):852–4. 10.1001/jamacardio.2021.0689. - PMC - PubMed

LinkOut - more resources